BRO · Q3 2025 Earnings

Cautious

Brown & Brown

Reported October 27, 2025

30-second summary

Brown & Brown posted $1.61B revenue (+35.4% YoY) and adjusted EPS of $1.05, with the headline lifted by the August 1 Accession close rather than underlying organic momentum — organic growth slowed to 3.5% total and management openly acknowledged retail organic of 2.7% is not a one-off. Margin guidance for FY2025 was raised to "up modestly" from flat, but Q4 segment commentary contains a real cut: specialty distribution organic is now expected to decline mid-single digits after running +4.6% last quarter. The tone has shifted from disciplined-but-confident to cautious, with structural concerns introduced around casualty rates and December property pricing.

Headline numbers

EPS

Q3 FY2025

$1.05

Revenue

Q3 FY2025

$1.61B

+35.4% YoY

Operating margin

Q3 FY2025

19.4%

Key financials

Q3 FY2025

Metric	Q3 FY2025	YoY	Q2 FY2025	QoQ
Revenue	$1.61B	+35.4%	$1.28B	+25.0%
EPS	$1.05	—	—	—
Operating margin	19.4%	—	—	—

Guidance

Company raised full-year FY2025 adjusted EBITDAC margin expectations to 'up modestly' from prior flat outlook, citing strong year-to-date performance; provided detailed Q4 forward guidance across revenue, margins, and segment organic growth.

Guidance is issued for the full year only, refreshed each quarter. Prior and new below are the same FY updated this quarter.

New guidance

Metric	Period	Guide	YoY
Operating Cash Flow to Revenue Ratio	FY 2025	23% to 25% range	—
Revenue	Q4 FY2025	$430 million to $450 million	—
Adjusted EBITDAC Margin	Q4 FY2025	Slightly below four-year margin	—
Amortization Expense	Q4 FY2025	$110 million to $115 million	—
Interest Expense	Q4 FY2025	$95 million to $100 million	—
Investment and Other Income	Q4 FY2025	$20 million to $25 million	—
Contingent Commissions	Q4 FY2025	$30 million to $40 million	—
Retail Segment Organic Growth	Q4 FY2025	Similar to Q3	—
Specialty Distribution Organic Growth	Q4 FY2025	Mid-single digits decline range	—

Changes to prior guidance

Metric	Period	Prior guide	New guide	Δ	Result
Adjusted EBITDAC Margin	FY 2025	Flat vs. 2024	Up modestly vs. 2024	Shifted from flat to modest upside	Raised

Segment performance

Q3 FY2025

Segment	Q3 FY2025	YoY
Commissions and fees	$1.55B	+34.2%
Investment and other income	$0.056B	+80.6%

Other KPIs

Q3 FY2025

Segment	Q3 FY2025
Organic Revenue growth	3.5%
EBITDAC - Adjusted	$587 million
EBITDAC Margin - Adjusted	36.6%
Income Before Income Taxes Margin	19.4%
Diluted Net Income Per Share - Adjusted	$1.05

Management tone

Q1 stable softening → Q2 cat property decel accelerating → Q3 organic reset acknowledged + casualty structurally challenged.

The "temporary headwind" framing is gone. In Q2 Powell attributed half the retail miss to rate pressure and half to lower new business, but characterized it as cyclical. This quarter Andy was direct: "we're not skirting the issue that was 2.7%" — and explicitly declined to call it a one-off adjustment. That is a fundamental reset of how investors should model retail organic going forward, not a quarterly nuance.

Two quarters ago casualty rate increases were framed as a tailwind. This quarter Powell introduced a structural concern: "Unless there's meaningful tort reform across the country, we expect continued upward pressure on rates on casualty lines... the casualty lines will continue to be challenging to place. This includes both rate and available limits." Rate increases that previously meant commission upside are now being recast as availability problems that hurt placement — a meaningful shift in how the casualty cycle is being characterized.

Specialty distribution moved from a Q2 bright spot to a Q4 decline in a single quarter. Andy: "we anticipate the organic growth rate for our specialty distribution segment could decline in the range of mid-single digits." No softening language, no "depending on" — a direct statement of expected contraction. Given this segment was running +4.6% organic in Q2, the velocity of the change is more concerning than the magnitude.

Property pricing commentary added a December tail-risk that wasn't on the prior call. Powell: "you get into December, and you get a couple markets that basically decide to get really aggressive because they still have unutilized capacity... it wouldn't surprise us if it happened at the end of the year." Management is flagging carriers potentially running a "blue light special" to use up reinsurance capacity — a scenario absent from Q2's softening narrative.

The economic outlook gained nuance: instead of "relatively stable," Powell described visible customer heterogeneity, with some industries hiring while others stay flat. Combined with employee benefits per-head compensation headwinds and customer plan modifications to manage healthcare spend, this signals softer organic demand into 2026.

Recurring themes management leaned on this quarter:

Margin expansion despite lower organic growth, driven by contingent commissions and Session acquisition impactEmployee benefits cost inflation (6-8% medical, 10%+ pharmacy) creating demand for consulting but offsetting by premium growth headwindsProperty market rate pressure persisting; casualty rates rising 5-10% primary, excess higher; ENF down 15-30%Lender-placed and wind/quake programs under pressure in Q4; government shutdown impacting Medicare SSA and flood (Write Your Own)Session integration on track; synergies expected over 3-year period through 2028Capital deployment active; balance sheet strong; continued M&A discipline with pipeline 'looking good domestically and internationally'

Risks management surfaced:

Government shutdown impacting Medicare Social Security set-aside and Write Your Own flood policy issuanceCasualty line rate pressures and availability constraints; potential need for tort reformLender-placed business growth deceleration due to competitive pressure and large installed baseENF property market continued downward rate pressure and potential December aggressive pricing from carriers with unutilized capacityEmployee benefits organic growth headwinds from per-head compensation model and customer plan modifications to manage healthcare spend

Q&A highlights

Josh Shanker · Bank of America

How should investors interpret the company's simultaneous authorization of a $1.5B buyback and continued M&A activity? Is one capital deployment option preferred over the other, or does the math work to make both equally attractive?

Management stated they continuously evaluate intrinsic stock value and will deploy capital to whichever option (buyback or M&A) represents the best long-term value. They declined to share specific mathematical thresholds, characterizing detailed disclosure as releasing their 'secret.' Management emphasized a rigorous capital allocation process and that M&A decisions factor in cultural fit alongside financial returns.

$1.5 billion buyback authorization23,000+ teammates globallyBoth buybacks and M&A considered based on valuation and cultural fit

What to watch into next quarter

Retail organic in Q4 — guided to "similar to Q3" (~2.7%); any further deceleration confirms the 2.7% level is itself transitional rather than the floor

Specialty distribution organic — watch whether the mid-single-digit decline materializes as guided or proves worse, given the Q2-to-Q4 velocity of the deterioration

Contingent commissions — guided $30M–$40M for Q4, with the range driven by storm-season outcomes; the low end would compress reported EBITDAC margin meaningfully

December property pricing — Powell's "blue light special" scenario; whether carriers with unused capacity get aggressive enough to reset 1/1 renewals lower

Accession Q4 revenue — the $430M–$450M range is the first hard datapoint for run-rate sizing; below the low end raises questions about synergy timing through 2028

FY2025 cash flow from ops / revenue ratio — guided 23%–25%; first hard-anchored cash conversion target the company has put on the table

Sources

Brown & Brown Q3 2025 press release (Exhibit 99.1, SEC filing): https://www.sec.gov/Archives/edgar/data/79282/000119312525251743/bro-ex99_1.htm
Brown & Brown Q3 2025 earnings call transcript and prepared remarks (management commentary from Powell Brown and Andy Watts)

Get the next brief, free.

We publish analyst-grade earnings briefs the same day or morning after every call — headline numbers, segment KPIs, Q&A highlights, and tone analysis. Free during beta.

This is not investment advice.